Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,456 | -1,386 | 2,802 | -13,177 | N/A |
| Depreciation Amortization | 181 | 758 | 532 | 347 | N/A |
| Accounts receivable | 217 | -170 | -661 | -523 | N/A |
| Accounts payable and accrued liabilities | 65 | -4,726 | -2,572 | -3,748 | N/A |
| Other Working Capital | 400 | -4,530 | -2,917 | -4,154 | N/A |
| Other Operating Activity | 433 | -12,508 | -13,642 | 7,891 | 0 |
| Operating Cash Flow | $-1,160 | $-22,562 | $-16,458 | $-13,364 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -1,857 | -1,708 | -729 | N/A |
| Other Investing Activity | 11 | 12 | -111 | -110 | 0 |
| Investing Cash Flow | $4 | $-1,845 | $-1,819 | $-839 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,636 | 4,652 | 4,346 | 4,267 | N/A |
| Other Financing Activity | -92 | -386 | -270 | -179 | 0 |
| Financing Cash Flow | $12,544 | $4,266 | $4,076 | $4,088 | $N/A |
| Exchange Rate Effect | 356 | 531 | 341 | 388 | N/A |
| Beginning Cash Position | 2,826 | 22,540 | 21,060 | 20,908 | N/A |
| End Cash Position | 14,750 | 2,930 | 7,200 | 11,181 | N/A |
| Net Cash Flow | $11,924 | $-19,610 | $-13,860 | $-9,727 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,160 | -22,562 | -16,458 | -13,364 | N/A |
| Capital Expenditure | -7 | -1,907 | -1,754 | -775 | N/A |
| Free Cash Flow | -1,167 | -24,469 | -18,212 | -14,139 | 0 |